BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26612613)

  • 1. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
    Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
    BMC Neurol; 2015 Nov; 15():246. PubMed ID: 26612613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
    Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
    Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
    J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Ricchiuti L; De Caro MF; Patti F; Vecchio R; Sorbi S; Trojano M
    Mult Scler; 2006 Dec; 12(6):787-93. PubMed ID: 17263008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
    Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
    Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function.
    Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
    Clin Neuropsychol; 2017 Jan; 31(1):179-192. PubMed ID: 27707354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for memory problems in multiple sclerosis.
    Dent A; Lincoln NB
    Br J Clin Psychol; 2000 Sep; 39(3):311-5. PubMed ID: 11033753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Normalisation and validation of the Brief Neuropsychological Battery as the reference neuropsychological test in multiple sclerosis].
    Duque P; Ibanez J; Del Barco A; Sepulcre J; de Ramon E; Fernandez-Fernandez O;
    Rev Neurol; 2012 Mar; 54(5):263-70. PubMed ID: 22362474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.
    Akbar N; Honarmand K; Kou N; Feinstein A
    J Neurol; 2011 Mar; 258(3):373-9. PubMed ID: 20924594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
    Forn C; Belenguer A; Parcet-Ibars MA; Avila C
    J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to detect cognitive dysfunction at early stages of multiple sclerosis?
    Deloire MS; Bonnet MC; Salort E; Arimone Y; Boudineau M; Petry KG; Brochet B
    Mult Scler; 2006 Aug; 12(4):445-52. PubMed ID: 16900758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cognition using the Rao's Brief Repeatable Battery of Neuropsychological Tests on a group of Brazilian patients with multiple sclerosis.
    Brooks JB; Borela MC; Fragoso YD
    Arq Neuropsiquiatr; 2011 Dec; 69(6):887-91. PubMed ID: 22297873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery.
    Portaccio E; Goretti B; Zipoli V; Iudice A; Pina DD; Malentacchi GM; Sabatini S; Annunziata P; Falcini M; Mazzoni M; Pia Amato M;
    Mult Scler; 2010 May; 16(5):611-7. PubMed ID: 20207783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
    Sonder JM; Burggraaff J; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2014 Apr; 20(4):481-8. PubMed ID: 24019305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
    Goretti B; Patti F; Cilia S; Mattioli F; Stampatori C; Scarpazza C; Amato MP; Portaccio E
    Neurol Sci; 2014 Jan; 35(1):79-82. PubMed ID: 24101117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis.
    Strober L; DeLuca J; Benedict RH; Jacobs A; Cohen JA; Chiaravalloti N; Hudson LD; Rudick RA; LaRocca NG;
    Mult Scler; 2019 Nov; 25(13):1781-1790. PubMed ID: 30334474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.